- CA$202.52m
- CA$326.93m
- CA$522.70m
- 61
- 66
- 74
- 74
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 209 | 279 | 288 | 438 | 523 |
Cost of Revenue | |||||
Gross Profit | 54.3 | 83 | 83 | 111 | 152 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 223 | 319 | 304 | 452 | 550 |
Operating Profit | -13.1 | -40.3 | -16.3 | -14 | -27 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -15.3 | -42.6 | -19.6 | -18.6 | -36.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | -12.5 | -39.7 | -17.3 | -15.5 | -30.1 |
Net Income Before Extraordinary Items | |||||
Net Income | -12.5 | -39.7 | -17.3 | -15.5 | -30.1 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -12.2 | -39.7 | -17.3 | -15.5 | -30.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.233 | -0.34 | -0.312 | -0.141 | -0.204 |
Special Dividends per Share |